Relvar

This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

GSK gets maintenance indication for Trelegy

GSK claims Trelegy has made the strongest start of any of GSK’s new Ellipta range of respiratory meds, which also includes Relvar/Breo (fluticasone furoate/vilanterol) and Anoro (vilanterol/umeclidinium

Latest news

EMA approves GSK’s triple COPD therapy

GSK has been bringing other new COPD therapies to market - including Advair successor Breo/Relvar (fluticasone furoate and vilanterol) and Anoro (umeclidinium bromide and vilanterol) - but with greater competition in the
GSK's Witty ends on a high, but warns 2017 looking 'uncertain'

At the moment, new respiratory products such as Relvar/Breo (fluticasone furoate/vilanterol) are covering the decline in Advair, which fell 20% to £975m ($1.2bn) in the fourth quarter of
GSK files first application for triple COPD therapy

protect its franchise with the launch of new two-drug combinations such as Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide).
New drugs breathe life into GSK's respiratory business

New asthma and COPD drugs such as Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide) added £243m ($319m) in the quarter, more than offsetting a 13% decline in Seretide
GSK's triple COPD therapy tops Symbicort in phase III trial

These include GSK's Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide), as well as Novartis' Ultibro (glycopyrronium/indacaterol), AZ's own Duaklir (aclidinium bromide/formoterol fumarate) and Boehringer

More from news
Approximately 3 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Lonely planet: why there is dwindling value in pharma travelling alone

An example is the real-world observational study GSK conducted for its respiratory treatment Relvar prior to regulatory approval.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Director, Healthcare Marketing Agency: Salary TBC

Project Manager/ Account Manager: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Digital Account Director: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Medical Writer: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Account Director, Medical Education: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Senior Medical Writer: Great salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

International Childhood Cancer Day 2019: The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues: Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups: A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...